Literature DB >> 35051410

Primary ciliary dyskinesia: a big data genomics approach.

Hannah M Mitchison1, Damian Smedley2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35051410     DOI: 10.1016/S2213-2600(22)00009-1

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial.

Authors:  Anne B Chang; Lucy C Morgan; Emma L Duncan; Mark D Chatfield; André Schultz; Paul J Leo; Gabrielle B McCallum; Aideen M McInerney-Leo; Steven M McPhail; Yuejen Zhao; Catherine Kruljac; Heidi C Smith-Vaughan; Peter S Morris; Julie M Marchant; Stephanie T Yerkovich; Anne L Cook; Danielle Wurzel; Lesley Versteegh; Hannah O'Farrell; Margaret S McElrea; Sabine Fletcher; Heather D'Antoine; Enna Stroil-Salama; Phil J Robinson; Keith Grimwood
Journal:  BMJ Open Respir Res       Date:  2022-05

2.  CFAP300 mutation causing primary ciliary dyskinesia in Finland.

Authors:  Rüdiger Schultz; Varpu Elenius; Mahmoud R Fassad; Grace Freke; Andrew Rogers; Amelia Shoemark; Tiina Koistinen; Mai A Mohamed; Jacqueline S Y Lim; Hannah M Mitchison; Anu I Sironen
Journal:  Front Genet       Date:  2022-09-30       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.